规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | SET2 is a specific TRPV2 antagonist with an IC50 of 0.46 μM. It inhibits the TRP channel and attenuates the migration of prostate cancer cells. Additionally, SET2 diminishes the elevation of cytoplasmic calcium induced by lysophosphatidic acid (LPA), an activator of TRPV2[1]. |
体外研究 | SET2 (20 μM; 24 h) inhibits the migration of PC-3M cells expressing TRPV2[1]. SET2 (20 μM; 24 h) suppresses the 2-APB-evoked current in HEK293T cells transiently co-transfected with TRPV2 and LPAR1[1]. SET2 (20 μM; 24 h) attenuates the rise in cytoplasmic calcium induced by LPA (0.1 μM; 3 min) and LPA-induced migration in PC-3M cells[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.48mL 0.50mL 0.25mL |
12.42mL 2.48mL 1.24mL |
24.85mL 4.97mL 2.48mL |
CAS号 | 2313525-20-9 |
分子式 | C17H21F3N4O2S |
分子量 | 402.435 |
别名 | |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(260.91 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |